{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:53:53Z","timestamp":1761929633377},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2377-12-104","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T00:48:43Z","timestamp":1354927723000},"source":"Crossref","is-referenced-by-count":5,"title":["4-Chloropropofol enhances chloride currents in human hyperekplexic and artificial mutated glycine receptors"],"prefix":"10.1186","volume":"12","author":[{"given":"Jeanne","family":"de la Roche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Leuwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Krampfl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertrud","family":"Haeseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Dengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,24]]},"reference":[{"issue":"9","key":"670_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.tig.2008.06.005","volume":"24","author":"RJ Harvey","year":"2008","unstructured":"Harvey RJ, Topf M, Harvey K, Rees MI: The genetics of hyperekplexia: more than startle!. Trends Genet. 2008, 24 (9): 439-447. 10.1016\/j.tig.2008.06.005.","journal-title":"Trends Genet"},{"issue":"911","key":"670_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/pmj.77.911.570","volume":"77","author":"V Praveen","year":"2001","unstructured":"Praveen V, Patole SK, Whitehall JS: Hyperekplexia in neonates. Postgraduate Medical Journal. 2001, 77 (911): 570-572. 10.1136\/pmj.77.911.570.","journal-title":"Postgraduate Medical Journal"},{"issue":"6","key":"670_CR3","first-page":"1334","volume":"51","author":"SG Ryan","year":"1992","unstructured":"Ryan SG, Dixon MJ, Nigro MA, Kelts KA, Markand ON, Terry JC, Shiang R, Wasmuth JJ, O'Connell P: Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q. AmJHumGenet. 1992, 51 (6): 1334-1343.","journal-title":"AmJHumGenet"},{"issue":"4","key":"670_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/brain\/103.4.985","volume":"103","author":"F Andermann","year":"1980","unstructured":"Andermann F, Keene DL, Andermann E, Quesney LF: Startle disease or hyperekplexia: further delineation of the syndrome. Brain. 1980, 103 (4): 985-997. 10.1093\/brain\/103.4.985.","journal-title":"Brain"},{"issue":"8","key":"670_CR5","first-page":"10","volume":"3","author":"JS Davies","year":"2010","unstructured":"Davies JS, Chung SK, Thomas RH, Robinson A, Hammond CL, Mullins JG, Carta E, Pearce BR, Harvey K, Harvey RJ, et al: The glycinergic system in human startle disease: a genetic screening approach. Front Mol Neurosci. 2010, 3 (8): 10-","journal-title":"Front Mol Neurosci"},{"issue":"28","key":"670_CR6","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.1523\/JNEUROSCI.1763-10.2010","volume":"30","author":"SK Chung","year":"2010","unstructured":"Chung SK, Vanbellinghen JF, Mullins JG, Robinson A, Hantke J, Hammond CL, Gilbert DF, Freilinger M, Ryan M, Kruer MC, et al: Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia. J Neurosci. 2010, 30 (28): 9612-9620.","journal-title":"J Neurosci"},{"issue":"3","key":"670_CR7","first-page":"173","volume":"1792","author":"R Planells-Cases","year":"2009","unstructured":"Planells-Cases R, Jentsch TJ: Chloride channelopathies. BiochimBiophysActa. 2009, 1792 (3): 173-189.","journal-title":"BiochimBiophysActa"},{"issue":"6","key":"670_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(06)70470-7","volume":"5","author":"MJ Bakker","year":"2006","unstructured":"Bakker MJ, van Dijk JG, van den Maagdenberg AM, Tijssen MA: Startle syndromes. Lancet Neurol. 2006, 5 (6): 513-524. 10.1016\/S1474-4422(06)70470-7.","journal-title":"Lancet Neurol"},{"issue":"11","key":"670_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0165-6147(02)02138-7","volume":"23","author":"B Laube","year":"2002","unstructured":"Laube B, Maksay G, Schemm R, Betz H: Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?. Trends PharmacolSci. 2002, 23 (11): 519-527. 10.1016\/S0165-6147(02)02138-7.","journal-title":"Trends PharmacolSci"},{"issue":"3","key":"670_CR10","first-page":"267","volume":"109","author":"MI Rees","year":"2001","unstructured":"Rees MI, Lewis TM, Vafa B, Ferrie C, Corry P, Muntoni F, Jungbluth H, Stephenson JB, Kerr M, Snell RG, et al: Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia. HumGenet. 2001, 109 (3): 267-270.","journal-title":"HumGenet"},{"issue":"4","key":"670_CR11","first-page":"351","volume":"5","author":"R Shiang","year":"1993","unstructured":"Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ: Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. NatGenet. 1993, 5 (4): 351-358.","journal-title":"NatGenet"},{"issue":"7","key":"670_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0387-7604(02)00095-5","volume":"24","author":"L Zhou","year":"2002","unstructured":"Zhou L, Chillag KL, Nigro MA: Hyperekplexia: a treatable neurogenetic disease. Brain Dev. 2002, 24 (7): 669-674. 10.1016\/S0387-7604(02)00095-5.","journal-title":"Brain Dev"},{"issue":"18","key":"670_CR13","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1002\/j.1460-2075.1994.tb06742.x","volume":"13","author":"D Langosch","year":"1994","unstructured":"Langosch D, Laube B, Rundstrom N, Schmieden V, Bormann J, Betz H: Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia. EMBO J. 1994, 13 (18): 4223-4228.","journal-title":"EMBO J"},{"issue":"1","key":"670_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/emboj\/16.1.110","volume":"16","author":"JW Lynch","year":"1997","unstructured":"Lynch JW, Rajendra S, Pierce KD, Handford CA, Barry PH, Schofield PR: Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel. EMBO J. 1997, 16 (1): 110-120. 10.1093\/emboj\/16.1.110.","journal-title":"EMBO J"},{"issue":"2","key":"670_CR15","first-page":"223","volume":"16","author":"K Becker","year":"2008","unstructured":"Becker K, Breitinger HG, Humeny A, Meinck HM, Dietz B, Aksu F, Becker CM: The novel hyperekplexia allele GLRA1(S267N) affects the ethanol site of the glycine receptor. EurJHumGenet. 2008, 16 (2): 223-228.","journal-title":"EurJHumGenet"},{"issue":"22","key":"670_CR16","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1523\/JNEUROSCI.23-22-08051.2003","volume":"23","author":"GS Findlay","year":"2003","unstructured":"Findlay GS, Phelan R, Roberts MT, Homanics GE, Bergeson SE, Lopreato GF, Mihic SJ, Blednov YA, Harris RA: Glycine receptor knock-in mice and hyperekplexia-like phenotypes: comparisons with the null mutant. JNeurosci. 2003, 23 (22): 8051-8059.","journal-title":"JNeurosci"},{"issue":"6","key":"670_CR17","first-page":"663","volume":"31","author":"SG Ryan","year":"1992","unstructured":"Ryan SG, Sherman SL, Terry JC, Sparkes RS, Torres MC, Mackey RW: Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. AnnNeurol. 1992, 31 (6): 663-668.","journal-title":"AnnNeurol"},{"issue":"2","key":"670_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/ALN.0b013e3181942b5b","volume":"110","author":"HT Nguyen","year":"2009","unstructured":"Nguyen HT, Li KY, daGraca RL, Delphin E, Xiong M, Ye JH: Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors. Anesthesiology. 2009, 110 (2): 326-332.","journal-title":"Anesthesiology"},{"issue":"3","key":"670_CR19","first-page":"619","volume":"104","author":"TG Hales","year":"1991","unstructured":"Hales TG, Lambert JJ: The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. BrJPharmacol. 1991, 104 (3): 619-628.","journal-title":"BrJPharmacol"},{"issue":"8","key":"670_CR20","first-page":"1707","volume":"122","author":"M Pistis","year":"1997","unstructured":"Pistis M, Belelli D, Peters JA, Lambert JJ: The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. BrJPharmacol. 1997, 122 (8): 1707-1719.","journal-title":"BrJPharmacol"},{"issue":"6","key":"670_CR21","first-page":"1875","volume":"107","author":"J Ahrens","year":"2008","unstructured":"Ahrens J, Leuwer M, Stachura S, Krampfl K, Belelli D, Lambert JJ, Haeseler G: A transmembrane residue influences the interaction of propofol with the strychnine-sensitive glycine alpha1 and alpha1beta receptor. AnesthAnalg. 2008, 107 (6): 1875-1883.","journal-title":"AnesthAnalg"},{"issue":"11","key":"670_CR22","first-page":"1846","volume":"41","author":"G Trapani","year":"1998","unstructured":"Trapani G, Latrofa A, Franco M, Altomare C, Sanna E, Usala M, Biggio G, Liso G: Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors. JMedChem. 1998, 41 (11): 1846-1854.","journal-title":"JMedChem"},{"issue":"1","key":"670_CR23","first-page":"338","volume":"297","author":"MD Krasowski","year":"2001","unstructured":"Krasowski MD, Jenkins A, Flood P, Kung AY, Hopfinger AJ, Harrison NL: General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. JPharmacolExpTher. 2001, 297 (1): 338-351.","journal-title":"JPharmacolExpTher"},{"issue":"Supplement 7","key":"670_CR24","first-page":"421","volume":"50","author":"J Ahrens","year":"2009","unstructured":"Ahrens J, de la Roche J, Foadi N, Krampfl K, Leuwer M, Haeseler G: Halogeniertes Propofol Eine neue Substanzklasse fuer die wirkungsvolle Modulation glycinerger Inhibition. Anaesthesiologie & Intensivmedizin. 2009, 50 (Supplement 7): 421-463.","journal-title":"Anaesthesiologie & Intensivmedizin"},{"issue":"3","key":"670_CR25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/j.1460-2075.1990.tb08172.x","volume":"9","author":"G Grenningloh","year":"1990","unstructured":"Grenningloh G, Schmieden V, Schofield PR, Seeburg PH, Siddique T, Mohandas TK, Becker CM, Betz H: Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes. EMBO J. 1990, 9 (3): 771-776.","journal-title":"EMBO J"},{"issue":"2","key":"670_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1073\/pnas.82.2.488","volume":"82","author":"TA Kunkel","year":"1985","unstructured":"Kunkel TA: Rapid and efficient site-specific mutagenesis without phenotypic selection. ProcNatlAcadSciUSA. 1985, 82 (2): 488-492.","journal-title":"ProcNatlAcadSciUSA"},{"issue":"9","key":"670_CR27","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1523\/JNEUROSCI.4675-03.2004","volume":"24","author":"SM O'Shea","year":"2004","unstructured":"O'Shea SM, Becker L, Weiher H, Betz H, Laube B: Propofol restores the function of \"hyperekplexic\" mutant glycine receptors in Xenopus oocytes and mice. J Neurosci. 2004, 24 (9): 2322-2327. 10.1523\/JNEUROSCI.4675-03.2004.","journal-title":"J Neurosci"},{"issue":"2","key":"670_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00656997","volume":"391","author":"OP Hamill","year":"1981","unstructured":"Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved Patch-Clamp Techniques for High-Resolution Current Recording from Cells and Cell-Free Membrane Patches. Pflugers Archiv-European Journal of Physiology. 1981, 391 (2): 85-100. 10.1007\/BF00656997.","journal-title":"Pflugers Archiv-European Journal of Physiology"},{"issue":"1","key":"670_CR29","first-page":"51","volume":"15","author":"K Krampfl","year":"2002","unstructured":"Krampfl K, Schlesinger F, Zorner A, Kappler M, Dengler R, Bufler J: Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R\/G nuclear editing. EurJNeurosci. 2002, 15 (1): 51-62.","journal-title":"EurJNeurosci"},{"issue":"2","key":"670_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0304-3940(87)90586-6","volume":"77","author":"C Franke","year":"1987","unstructured":"Franke C, Hatt H, Dudel J: Liquid Filament Switch for Ultra-Fast Exchanges of Solutions at Excised Patches of Synaptic Membrane of Crayfish Muscle. Neurosci Lett. 1987, 77 (2): 199-204. 10.1016\/0304-3940(87)90586-6.","journal-title":"Neurosci Lett"},{"issue":"1","key":"670_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(01)01558-8","volume":"435","author":"K Krampfl","year":"2002","unstructured":"Krampfl K, Wolfes H, Dengler R, Bufler J: Kinetic analysis of the agonistic and blocking properties of pentobarbital on recombinant rat alpha(1)beta(2)gamma(2S) GABA(A) receptor channels. Eur J Pharmacol. 2002, 435 (1): 1-8. 10.1016\/S0014-2999(01)01558-8.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"670_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/sj.bjp.0706254","volume":"145","author":"G Haeseler","year":"2005","unstructured":"Haeseler G, Ahrens J, Krampfl K, Bufler J, Dengler R, Hecker H, Aronson JK, Leuwer M: Structural features of phenol derivatives determining potency for activation of chloride currents via alpha(1) homomeric and alpha(1)beta heteromeric glycine receptors. Br J Pharmacol. 2005, 145 (7): 916-925. 10.1038\/sj.bjp.0706254.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"670_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1124\/jpet.111.185140","volume":"340","author":"PA Castro","year":"2012","unstructured":"Castro PA, Figueroa M, Yevenes GE, San Martin LS, Aguayo LG: The basic property of Lys385 is important for potentiation of the human alpha1 glycine receptor by ethanol. J Pharmacol Exp Ther. 2012, 340 (2): 339-349. 10.1124\/jpet.111.185140.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"670_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1085\/jgp.20028530","volume":"119","author":"M Beato","year":"2002","unstructured":"Beato M, Groot-Kormelink PJ, Colquhoun D, Sivilotti LG: Openings of the rat recombinant alpha 1 homomeric glycine receptor as a function of the number of agonist molecules bound. J Gen Physiol. 2002, 119 (5): 443-466. 10.1085\/jgp.20028530.","journal-title":"J Gen Physiol"},{"issue":"6","key":"670_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00249-003-0286-y","volume":"32","author":"B Mohammadi","year":"2003","unstructured":"Mohammadi B, Krampfl K, Cetinkaya C, Moschref H, Grosskreutz J, Dengler R, Bufler J: Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta glycine receptor channels. Eur Biophys J. 2003, 32 (6): 529-536. 10.1007\/s00249-003-0286-y.","journal-title":"Eur Biophys J"},{"issue":"10","key":"670_CR36","first-page":"1805","volume":"34","author":"NL Absalom","year":"2009","unstructured":"Absalom NL, Schofield PR, Lewis TM: Pore structure of the Cys-loop ligand-gated ion channels. NeurochemRes. 2009, 34 (10): 1805-1815.","journal-title":"NeurochemRes"},{"issue":"4","key":"670_CR37","first-page":"2086","volume":"16","author":"G Maksay","year":"2008","unstructured":"Maksay G, Nemes P, Vincze Z, Biro T: Synthesis of (nor)tropeine (di)esters and allosteric modulation of glycine receptor binding. BioorgMedChem. 2008, 16 (4): 2086-2092.","journal-title":"BioorgMedChem"},{"issue":"4","key":"670_CR38","first-page":"2023","volume":"284","author":"JE Carland","year":"2009","unstructured":"Carland JE, Cooper MA, Sugiharto S, Jeong HJ, Lewis TM, Barry PH, Peters JA, Lambert JJ, Moorhouse AJ: Characterization of the effects of charged residues in the intracellular loop on ion permeation in alpha 1 glycine receptor-channels. JBiolChem. 2009, 284 (4): 2023-30.","journal-title":"JBiolChem"},{"issue":"15","key":"670_CR39","doi-asserted-by":"publisher","first-page":"13414","DOI":"10.1074\/jbc.M110.204610","volume":"286","author":"M Moroni","year":"2011","unstructured":"Moroni M, Meyer JO, Lahmann C, Sivilotti LG: In Glycine and GABAA Channels, Different Subunits Contribute Asymmetrically to Channel Conductance via Residues in the Extracellular Domain. J Biol Chem. 2011, 286 (15): 13414-13422. 10.1074\/jbc.M110.204610.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"670_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuint.2007.06.009","volume":"52","author":"G Maksay","year":"2008","unstructured":"Maksay G, Biro T, Laube B, Nemes P: Hyperekplexia mutation R271L of alpha1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3 H]strychnine binding. NeurochemInt. 2008, 52 (1\u20132): 235-240.","journal-title":"NeurochemInt"},{"issue":"6649","key":"670_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/38738","volume":"389","author":"SJ Mihic","year":"1997","unstructured":"Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, et al: Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature. 1997, 389 (6649): 385-389. 10.1038\/38738.","journal-title":"Nature"},{"issue":"4","key":"670_CR42","first-page":"731","volume":"129","author":"MD Krasowski","year":"2000","unstructured":"Krasowski MD, Harrison NL: The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations. BrJPharmacol. 2000, 129 (4): 731-743.","journal-title":"BrJPharmacol"},{"key":"670_CR43","first-page":"8","volume":"2011","author":"BA Graham","year":"2011","unstructured":"Graham BA, Tadros MA, Schofield PR, Callister RJ: Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse. J Physiol. 2011, 2011: 8-","journal-title":"J Physiol"},{"issue":"2","key":"670_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1152\/physrev.00029.2001","volume":"82","author":"TJ Jentsch","year":"2002","unstructured":"Jentsch TJ, Stein V, Weinreich F, Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev. 2002, 82 (2): 503-568.","journal-title":"Physiol Rev"},{"issue":"5","key":"670_CR45","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuron.2005.01.028","volume":"45","author":"J Grudzinska","year":"2005","unstructured":"Grudzinska J, Schemm R, Haeger S, Nicke A, Schmalzing G, Betz H, Laube B: The beta subunit determines the ligand binding properties of synaptic glycine receptors. Neuron. 2005, 45 (5): 727-739. 10.1016\/j.neuron.2005.01.028.","journal-title":"Neuron"},{"issue":"1","key":"670_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","volume":"56","author":"JW Lynch","year":"2009","unstructured":"Lynch JW: Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2009, 56 (1): 303-309. 10.1016\/j.neuropharm.2008.07.034.","journal-title":"Neuropharmacology"},{"issue":"5","key":"670_CR47","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/0896-6273(89)90195-5","volume":"2","author":"H Sontheimer","year":"1989","unstructured":"Sontheimer H, Becker CM, Pritchett DB, Schofield PR, Grenningloh G, Kettenmann H, Betz H, Seeburg PH: Functional chloride channels by mammalian cell expression of rat glycine receptor subunit. Neuron. 1989, 2 (5): 1491-1497. 10.1016\/0896-6273(89)90195-5.","journal-title":"Neuron"},{"issue":"6","key":"670_CR48","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00001756-199504190-00018","volume":"6","author":"B Laube","year":"1995","unstructured":"Laube B, Langosch D, Betz H, Schmieden V: Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids. Neuroreport. 1995, 6 (6): 897-900. 10.1097\/00001756-199504190-00018.","journal-title":"Neuroreport"},{"issue":"6","key":"670_CR49","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/j.1460-2075.1996.tb00469.x","volume":"15","author":"B Hartenstein","year":"1996","unstructured":"Hartenstein B, Schenkel J, Kuhse J, Besenbeck B, Kling C, Becker CM, Betz H, Weiher H: Low level expression of glycine receptor beta subunit transgene is sufficient for phenotype correction in spastic mice. EMBO J. 1996, 15 (6): 1275-1282.","journal-title":"EMBO J"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-12-104\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T20:04:10Z","timestamp":1643832250000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-12-104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,24]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-12-104","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,24]]},"article-number":"104"}}